pharma
PhRMA blames hospitals for rising drug prices, hospitals association responds
September 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Drug pricing, PhRMA, hospitals, pharma
The American pharmaceutical industry trade lobby PhRMA has suggested that hospitals are to blame for high drug prices as the …
Novo Nordisk stockpiles 16 weeks’ worth of insulin in preparation for hard Brexit
September 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Novo Nordisk, UK, brexit, insulin, pharma, stockpiles
Danish multinational Novo Nordisk has announced that they are increasing their stocks of insulin products to ensure that there are …
BMS’ Opdivo fails to win over NICE as adjuvant melanoma therapy
September 10, 2018Sales and Marketing BMS, NHS, NICE, melanoma, opdivo, pharma
Bristol-Myers Squibb has failed to convince NICE to approve the use of its PD-1 inhibitor immunotherapy Opdivo (nivolumab) as an …
Keytruda scores ground-breaking European approval in lung cancer subgroup
September 10, 2018Sales and Marketing Cancer, EU, Europe, MSD, Merck, NSCLC, keytruda, lung cancer, pharma
Keytruda (pembrolizumab) has chalked up yet another approval for MSD, this time in Europe in combination with permextred and platinum-based …
GSK’s Nucala data insufficient for US COPD approval
September 10, 2018Sales and Marketing COPD, FDA, GSK, Nucala, US, pharma
GlaxoSmithKline has suffered a regulatory blow in the label expansion of its interleukin-5 (IL5) inhibitor Nucala (mepolizumab), with the FDA …
Akcea cuts 10% of staff following FDA rejection
September 10, 2018Manufacturing and Production, Sales and Marketing Akcea, FDA, Waylivra, pharma
Akcea Therapeutics has been hit hard by the FDA’s decision to reject its drug Waylivra (volanesorsen) for the treatment of …
NICE rejects Roche’s Ocrevus in primary progressive multiple sclerosis
September 10, 2018Sales and Marketing NICE, Ocrevus, Roche, UK, multiple sclerosis, pharma
Of the 100,000 MS patients in England, around one in eight have the primary progressive form (PPMS), which brings debilitating …
UK Government to invest £200m in IT and technology boost for NHS
September 7, 2018Medical Communications, Sales and Marketing AI, Matt Hancock, NHS, NHS expo, pharma
The UK Government has lifted the curtain on plans invest more than £200 million to leverage innovations in technology and …
Gilead and Galapagos’ ankylosing spondylitis drug hits Phase 2 trial goal
September 7, 2018Medical Communications, Research and Development Galapagos, Gilead, ankylosing spondylitis, filgotinib, pharma
Gilead and Galapagos have announced that their jointly-developed selective JAK1 inhibitor filgotinib has met its primary endpoint in a Phase …
A rational new approach to cancer treatment
September 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, University of East Anglia, feature, pharma
Researchers at the University of East Anglia have developed a new targeted cancer therapy which utilises nanoparticles to deliver treatment …
Novartis sells key Sandoz US portfolios to Aurobindo for $1bn
September 6, 2018Sales and Marketing Aurobindo, Novartis, Sandoz, pharma
Novartis has revealed it is to sell the dermatology and generic US oral solids portfolios of its generics arm Sandoz …
Teva drops MS and Huntington’s disease drug laquinimod, leaving rights to Active Biotech
September 6, 2018Medical Communications, Research and Development Active Biotech, Laquinimod, Teva, pharma
Israeli multinational Teva Pharmaceutical has decided to discontinue the development of laquinimod. As such, all rights for the orally administered …
GSK to axe 650 positions across US workforce
September 6, 2018Manufacturing and Production GSK, GlaxoSmithKline, pharma
GlaxoSmithKline has announced its intention to cut 650 employees from its current US workforce, with the cutbacks coming as part …
FDA turns to real-world evidence to improve regulatory process
September 5, 2018Medical Communications, Research and Development, Sales and Marketing FDA, pharma, real world data, real world evidence, real-world data, real-world evidence
The FDA has announced its intention to incorporate real-world data elements to a greater degree into its regulatory decision-making framework …
Europe-wide policy could boost generics market, study suggests
September 5, 2018Research and Development Europe, generics, growth, markets, pharma
A Europe-wide policy covering the generic pharmaceutical market would facilitate significant growth in the pharmaceutical sector according to a new …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
